Pinned post
馃搳 Massive valuation gap alert for $INJ
Injective has cracked the global Top 10 Layer-1s by 365-day revenue, generating $3.6M
The market isn鈥檛 pricing it in (yet):
P/S Ratio Comparison (Top Revenue L1s)
鈻笍 Peer Average: ~1304x MC-to-revenue
鈻笍 Injective: 156x
That鈥檚 a ~88% discount to the sector average.
Injective is criminally undervalued.
Injective has cracked the global Top 10 Layer-1s by 365-day revenue, generating $3.6M
The market isn鈥檛 pricing it in (yet):
P/S Ratio Comparison (Top Revenue L1s)
鈻笍 Peer Average: ~1304x MC-to-revenue
鈻笍 Injective: 156x
That鈥檚 a ~88% discount to the sector average.
Injective is criminally undervalued.
Onchain revenue on Injective is rapidly rising.View quoted post on X
And the revenue is used to directly carry out $INJ buybacks.
It's time to accelerate this year.